Health

  • April 16, 2026

    Fed. Circ. Says Judge Wrongly Axed Teva's $177M Eli Lilly Win

    The Federal Circuit ruled Thursday that a Massachusetts federal judge was wrong to overturn a $177 million jury verdict that Teva won against Eli Lilly & Co. on headache drug patents, finding that contrary to the judge's finding, the patents are not invalid.

  • April 16, 2026

    Feds Can't Stay Trans Healthcare Orders During Appeal

    The Trump administration won't be able to enforce two executive orders that ban federal funding for gender-affirming care for patients under the age of 19 while the federal government appeals a nationwide injunction blocking the orders, the Fourth Circuit ruled Thursday. 

  • April 16, 2026

    Del. Rejects Fiduciary Claim Over Competing Opioid Clinic

    The Delaware Chancery Court on Thursday largely rejected a healthcare company's claims that a former executive unlawfully competed against it by launching a nearby opioid treatment clinic, finding only a narrow breach of fiduciary duty and awarding just over $1,600 in damages.

  • April 16, 2026

    DOL Benefits Chief Pressed On Labor Secretary's Conduct

    The head of the U.S. Department of Labor's employee benefits arm faced tough questions from House Democrats at an oversight hearing Thursday, fielding questions about the labor secretary's on-the-job conduct as well as the DOL's take on mental health parity enforcement. 

  • April 16, 2026

    Texas Patients Say Defective Sutures Caused Disfigurement

    Four patients who received cosmetic facial procedures told a Texas federal court that sutures used during their procedures caused painful facial bacterial abscesses and permanent scarring, claiming the sutures never received FDA approval.

  • April 16, 2026

    Armed Services Board Says DHA Agreement Wasn't A Contract

    The Armed Services Board of Contract Appeals dismissed an appeal from a Defense Health Agency supply vendor whose agreement was terminated years before its end date, finding it did not amount to a contract.

  • April 16, 2026

    Katten Partner Rejoins Epstein Becker In DC For 3rd Time

    Epstein Becker Green LLP has rehired, for the third time, a healthcare transactional attorney who focuses his practice on guiding hospital systems, private equity-backed entities and professional practices on transactional matters and regulatory compliance.

  • April 15, 2026

    Larry King's Estate Says Supplement Co. Still Using His Name

    Larry King's estate sued operators of a prostate health supplement company in California state court Wednesday, alleging they continued using his name and likeness to advertise their product even after striking a legal settlement agreeing to stop.

  • April 15, 2026

    Consumer Cases Drive Class Action Spike, Report Says

    Federal class action filings spiked in 2025 after nearly a decade of relative stability, fueled by a surge in consumer protection lawsuits tied to data breaches, digital commerce and online accessibility claims, according to a new report from Lex Machina.

  • April 15, 2026

    'A Bunch Of Games': MDL Judge Irked By Meta, AGs Sparring

    A California federal judge appeared skeptical Wednesday of Meta Platforms Inc.'s request for a summary judgment win over claims by state attorneys general in multidistrict social media addiction litigation, saying repeatedly that many disputes should be resolved at trial and panning some arguments by both sides as "a bunch of games."

  • April 15, 2026

    Hims & Hers Providers Can't Duck Suit Over Student's Suicide

    Medical providers for telehealth company Hims & Hers can't escape a wrongful death lawsuit from the family of a Washington State University freshman who died by suicide in 2023, according to a Washington state judge's order denying summary judgment motions from five individual defendants.

  • April 15, 2026

    Amneal Trims But Can't Nix AGs' Drug Price-Fixing Suit

    There is enough evidence from which a jury could conclude that Amneal Pharmaceuticals participated in a conspiracy to fix the price of an epilepsy medication, but not enough to show it participated in the overarching antitrust conspiracy alleged by dozens of state attorneys general, a Connecticut federal judge ruled Wednesday.

  • April 15, 2026

    Drugmaker Aquestive's Brass Sued Over FDA Setback

    Executives and directors of pharmaceutical company Aquestive Therapeutics Inc. were hit with a shareholder's derivative suit Wednesday accusing them of ignoring deficiencies in a research study for Aquestive's allergic reaction treatment, which eventually prompted the U.S. Food and Drug Administration to reject the company's new drug application.

  • April 15, 2026

    'Law, Not Liturgy'?: 9th Circ. Split Over Faith Bias COVID Suit

    Eight judges dissented Wednesday from the denial of an en banc Ninth Circuit rehearing of a panel's decision not to revive a Christian hospital worker's religious bias lawsuit alleging she was fired for refusing COVID-19 nasal testing, with one dissenting judge saying "courts are unwelcome guests" when deciding the veracity of an individual's belief.

  • April 15, 2026

    Judge Won't Move 'Maya' Case For Retrial

    A Florida judge on Wednesday denied a hospital's request to move a retrial of Netflix documentary subject Maya Kowalski's claims against the hospital from Sarasota to St. Petersburg, citing the difficulty and expense of moving the 8-year-old case to a new circuit and judge.

  • April 15, 2026

    Aluminum Co. Settles Trans Worker's Suit Over Health Plan

    A subsidiary of Kaiser Aluminum has agreed to resolve a lawsuit claiming it discriminated against transgender employees by excluding coverage for medical treatments related to gender-affirming care from its health plan, according to a filing in Washington federal court.

  • April 15, 2026

    What To Know About DOL's Benefits Enforcement Update

    The U.S. Department of Labor's employee benefits arm recently issued updated enforcement guidance that highlighted the agency's goal of shifting to focus more on breaches of the fiduciary duty of loyalty under federal benefits law. Here are three things experts said stood out about the DOL's update.

  • April 15, 2026

    Women's Health Co. Accused Of Unauthorized Data Sharing

    A private women's healthcare system is facing a proposed class action in Pennsylvania federal court that alleges it allowed third parties to use sensitive patient information without consent or notice.

  • April 15, 2026

    Fertility Biz Progyny Hit With TM Suit In Pennsylvania

    Fertility benefit management company Progyny Inc.'s expansion into pregnancy and postpartum care while using the "Progyny" trademark will create confusion in the marketplace by overlapping with similar but differently spelled marks, a new lawsuit from ProgenyHealth LLC claims.

  • April 15, 2026

    Fed. Circ. Won't Make It Harder To Undo CICA Stay Overrides

    The Federal Circuit declined to impose a heightened standard of review when judges are considering a federal agency's decision to override an automatic pause on contract performance during a bid protest at the U.S. Government Accountability Office.

  • April 15, 2026

    Shell, Enviro Group Ordered To 'Actually Speak For 4 Hours'

    An apparently frustrated Connecticut federal judge on Wednesday ordered Shell and an environmental advocacy group to try to resolve remaining disputes in Clean Water Act litigation before they appear before him again, ruling that counsel "must actually speak for four hours," and "time spent composing e-mails, even lengthy ones" doesn't count.

  • April 15, 2026

    Firings Over Vax Refusals Arbitrable, Police Union Tells Court

    The union representing Massachusetts state police troopers told an intermediate appellate court Wednesday that disagreement over the meaning of "just cause" triggers a right to arbitrate disciplinary actions, including the firings of 13 officers over their refusal to receive COVID-19 vaccinations.

  • April 15, 2026

    NC Judge Won't Undo $4M Philips Copyright Verdict

    A North Carolina federal judge has refused to erase a $4 million jury verdict against independent service organization Transtate Equipment Co. for violations of the Digital Millennium Copyright Act, saying trial evidence provided a "firm basis" to support the jury's statutory damages award.

  • April 15, 2026

    Pa. Health System Sheds Privacy Claim In Meta Pixel Action

    A Pennsylvania regional health system escaped allegations that it intruded on the privacy of visitors to its website by using Meta's Pixel but must face a negligence claim, a Pennsylvania federal judge ruled in trimming a proposed class action.

  • April 15, 2026

    Biopharma Co. Says Ex-Worker Used Files To Build AI Rival

    A biopharmaceutical consulting firm's ex-contractor illegally downloaded thousands of proprietary internal files and emails that he then used to launch a rival company powered by artificial intelligence, the firm claimed in a lawsuit, alleging that the former contractor violated federal trade secrets law.

Expert Analysis

  • Unique Aspects Of Texas' Approach To AI Regulation

    Author Photo

    The Texas Responsible AI Governance Act — which will soon be the sole comprehensive artificial intelligence law in the U.S. — pulls threads from EU and Colorado laws but introduces more targeted rules with fewer obligations on commercial entities, say attorneys at MVA Law.

  • 3 Takeaways From FDA Cell And Gene Therapy Draft Guidance

    Author Photo

    The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • IP Ownership Risk Grows In Booming Cancer Drug Market

    Author Photo

    The ownership of intellectual property has become strategically decisive in deals involving valuable cancer therapeutics known as ADCs, as highlighted by the recent Takeda-Innovent deal, with the commercial value of a license resting on the integrity and defensibility of the underlying technology, say attorneys at Loeb & Loeb.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • Surveying The Healthcare Policy Landscape Post-Shutdown

    Author Photo

    With last week's agreement to reopen the federal government, at least through the end of January, key healthcare legislation that has been in limbo since a December 2024 spending bill fell apart may recapture the attention of Congress, say attorneys at Faegre Drinker.

  • FDA Biosimilar Guidance Should Ease Biologics Development

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.

  • Litigation Funding Could Create Ethics Issues For Attorneys

    Author Photo

    A litigation investor’s recent complaint claiming a New York mass torts lawyer effectively ran a Ponzi scheme illustrates how litigation funding arrangements can subject attorneys to legal ethics dilemmas and potential liability, so engagement letters must have very clear terms, says Matthew Feinberg at Goldberg Segalla.

  • E-Discovery Quarterly: Recent Rulings On Dynamic Databases

    Author Photo

    Several recent federal court decisions illustrate how parties continue to grapple with the discovery of data in dynamic databases, so counsel involved in these disputes must consider how structured data should be produced consistent with the requirements of the Federal Rules of Civil Procedure, say attorneys at Sidley.

  • Prison Body Cams Raise Health Privacy Compliance Issues

    Author Photo

    The increasing use of prison staff body cameras to enhance transparency and safety presents correctional healthcare partners with new risk management questions where they must carefully reconcile the benefits of surveillance with the imperative to protect patient privacy, say attorneys at Gordon Rees.

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

  • Series

    Law School's Missed Lessons: Networking 101

    Author Photo

    Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • How Cos. Can Prep For Tightened Calif. Data Breach Notices

    Author Photo

    Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.

  • Employer Considerations After 11th Circ. Gender Care Ruling

    Author Photo

    The Eleventh Circuit's en banc decision in Lange v. Houston County, Georgia, finding that a health plan did not violate Title VII by excluding coverage for gender-affirming care, shows that plans must be increasingly cognizant of federal and state liability as states pass varying mandates, say attorneys at Miller & Chevalier.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.